Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management

Equality impact assessment final (PDF 362 KB)

Committee member list (PDF 135 KB)

Consultation comments and responses (PDF 1.25 MB)

Draft guidance consultation

Evidence review D1 - Antibiotics unknown younger infants BM (PDF 960 KB)

Evidence review D2 - Antibiotics unknown older infants BM (PDF 1.82 MB)

Evidence review D3 - Antibiotics unknown adults BM (PDF 1.18 MB)

Evidence review E1 - Antibiotics strep pneumoniae BM (PDF 979 KB)

Evidence review E2 - Antibiotics haemophilis influenzae BM (PDF 1.03 MB)

Evidence review E3 - Antibiotics group B strep BM (PDF 833 KB)

Evidence review E4 - Antibiotics gram negative bacilli BM (PDF 901 KB)

Evidence review E5 - Antibiotics listeria BM (PDF 799 KB)

Evidence review E6 - Antibiotics neisseria BM (PDF 1.13 MB)

Evidence review F1 - Antibiotics for MD (PDF 870 KB)

Evidence review G1 - Fluid restriction (PDF 884 KB)

Evidence review G2 - Osmotic agents BM (PDF 952 KB)

Evidence review G3 - ICP monitoring BM (PDF 1.12 MB)

Evidence review G4 - Corticosteroids BM (PDF 1.42 MB)

Evidence review H - Corticosteroids MD (PDF 939 KB)

Evidence review I1 - Long term complications BM (PDF 3.56 MB)

Evidence review I2 - Long term complications MD (PDF 1.67 MB)

Evidence review J1 - Recurrent BM (PDF 1.49 MB)

Evidence review J2 - Recurrent MD (PDF 952 KB)

Evidence review K1 - Info for suspected BM or MD (PDF 1.82 MB)

Evidence review K2 - Support for suspected BM or MD (PDF 1.22 MB)

Evidence review K3 - Info confirmed BM or MD (PDF 1.51 MB)

Evidence review K4 - Support confirmed BM or MD (PDF 1.49 MB)

Evidence review A1 - Symptoms & signs BM (PDF 3.82 MB)

Evidence review A2 - Risk factors BM.pdf (PDF 1.05 MB)

Evidence review A3 - Symptoms & signs MD (PDF 2.57 MB)

Evidence review A4 - Risk factors MD.pdf (PDF 1.34 MB)

Evidence review B1 - Blood & urine investigations BM (PDF 2.65 MB)

Evidence review B2 - Blood & urine investigations MD (PDF 1.7 MB)

Evidence review B3 - CSF parameters BM (PDF 7.93 MB)

Evidence review B4 - Brain herniation (PDF 916 KB)

Evidence review B5 - Neuroimaging prior to lumbar puncture (PDF 1000 KB)

Evidence review C1 - Antibiotic timing BM (PDF 1.12 MB)

Evidence review C2 - Antibiotic timing MD (PDF 1.29 MB)

Draft guideline (PDF 991 KB)

Supporting documentation Methods  (PDF 641 KB)

Supporting documentation Acknowledgments (PDF 180 KB)

Committee member list (PDF 141 KB)

Accessible version Interests register (PDF 507 KB)

Economic plan (PDF 88 KB)

Committee meeting

Minutes 1 (PDF 246 KB)

Minutes 2 (PDF 228 KB)

Minutes 3 (PDF 245 KB)

Minutes 4 (PDF 248 KB)

Minutes 5 (PDF 246 KB)

Minutes 6 (PDF 242 KB)

Minutes 7 (PDF 239 KB)

Minutes 8 (PDF 244 KB)

Minutes 9 (PDF 240 KB)

Minutes 10 (PDF 244 KB)

Minutes 11 (PDF 243 KB)

Minutes 12 (PDF 243 KB)

Minutes 13 (PDF 241 KB)

Minutes 14 Updated (PDF 247 KB)

Minutes 15 (PDF 256 KB)

Minutes 16 Updated (PDF 262 KB)

Minutes 17 (PDF 260 KB)

Minutes 18 (PDF 259 KB)

Minutes 19 (PDF 160 KB)

Minutes 20 (PDF 157 KB)

Minutes 21 (PDF 157 KB)

Minutes 22 (PDF 174 KB)

Minutes 23 (PDF 160 KB)

Minutes 24 (MSWord 113 KB)

Minutes 26 (MSWord 92 KB)

Minutes 27 (MSWord 91 KB)

Consultation comments and responses (PDF 408 KB)

Draft scope consultation

Draft scope (PDF 291 KB)